Reply to A. Ota et al, Y.H. Kim, and N. Van Der Steen et al

J Clin Oncol. 2017 Feb 20;35(6):694-695. doi: 10.1200/JCO.2016.70.6978. Epub 2016 Dec 5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Carcinoma, Non-Small-Cell Lung*
  • Combined Modality Therapy
  • Gefitinib
  • Humans
  • Lung Neoplasms*
  • Pemetrexed

Substances

  • Pemetrexed
  • Gefitinib